Laroxin XR
On the Bulgarian pack: Лароксин XR 37,5 mg твърди капсули с удължено освобождаване
37,5 mg prolonged-release capsules, hard · prolonged release capsules, hard
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Venlafaxine hydrochloride
- Made by
- Teva B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet read the official leaflet for this product. The exact uses and dose are in the leaflet inside the pack. Open the official leaflet
How it works
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (venlafaxine hydrochloride). It describes the substance, not this Bulgarian product — its uses and doses can differ.
The mechanism of action of venlafaxine in the treatment of MDD, GAD, SAD, and PD is unclear, but is thought to be related to the potentiation of serotonin and norepinephrine in the central nervous system, through inhibition of their reuptake.
Following absorption, venlafaxine undergoes extensive presystemic metabolism in the liver, primarily to ODV, but also to N-desmethylvenlafaxine, N,O-didesmethylvenlafaxine, and other minor metabolites.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-12-02
Safety of the active substance
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (venlafaxine hydrochloride). It describes the substance, not this Bulgarian product — its uses and doses can differ.
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behavior in pediatric and young adult patients in short-term studies.
- Hypersensitivity to venlafaxine hydrochloride, desvenlafaxine succinate, or any excipients in the venlafaxine hydrochloride extended-release capsules formulation ( 4 ).
- Concomitant use of monoaminoxidase inhibitors (MAOIs) or within 14 days of discontinuing an MAOI ( 4, 5.2, 7.1 ).
The most common adverse reactions leading to discontinuation in ≥1% of the venlafaxine hydrochloride extended-release capsules treated patients in the short-term studies (up to 12 weeks) across indications are shown in Table 7.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States35 matching products
Spain3 matching products
Canada19 matching products
- VENLAFAXINE XR 37.5 mg · capsule (extended-release)5 makers
- ACT VENLAFAXINE XR 37.5 mg · capsule (extended-release)
- APO-VENLAFAXINE XR 37.5 mg · capsule (extended-release)
- AURO-VENLAFAXINE XR 37.5 mg · capsule (extended-release)
- BIO-VENLAFAXINE XR 37.5 mg · capsule (extended-release)
- EFFEXOR XR 37.5 mg · capsule (extended-release)
- M-VENLAFAXINE XR 37.5 mg · capsule (extended-release)
- MAR-VENLAFAXINE XR 37.5 mg · capsule (extended-release)
Netherlands9 matching products
- Venlafaxine retard Teva 37 37,5 mg · capsule met verlengde afgifte, hard2 makers
- Efexor XR 37 37,5 mg · capsule met verlengde afgifte, hard
- Venfalex XR 37 37,5 mg · capsule met verlengde afgifte, hard
- Venlafaxine Aurobindo 37 37,5 mg · capsule met verlengde afgifte, hard
- Venlafaxine HCl Retard Alembic 37 37,5 mg · capsule met verlengde afgifte, hard
- Venlafaxine HCl Sandoz XR 37 37,5 mg · capsule met verlengde afgifte, hard
- Venlafaxine retard Krka 37 37,5 mg · capsule met verlengde afgifte, hard
- Venlafaxine Retard Viatris 37 37,5 mg · capsule met verlengde afgifte, hard
SwitzerlandNo exact match for this strength and form
Details
| Made by | Teva B.V. · Netherlands |
|---|---|
| Active substance | Venlafaxine hydrochloride |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 37,5 mg prolonged-release capsules, hard |
| Form | prolonged release capsules, hard |
| Pack sizes | 10 · 14 · 20 · 28 · 30 · 50 · 98 · 100 |
| Classification | N06AX16 · Pain, sleep, mood, epilepsy and the brain |
| Name in the register | Лароксин XR 37,5 mg твърди капсули с удължено освобождаване |
| Reg. no. | 20220203 |
Source: Bulgarian Drug Agency register · 2026-08-01 · not reviewed by a clinician
Източник: Изпълнителна агенция по лекарствата (ИАЛ). The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Other strengths and forms
7 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- prolonged release capsules, hard7 products
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.